67 results
424B3
MRZM
Marizyme, Inc.
16 Nov 23
Prospectus supplement
6:08am
of damage to vascular grafts leading to major adverse cardiac events or vascular injury requiring mitigation through clinical performance data, non
424B3
MRZM
Marizyme, Inc.
17 Oct 23
Prospectus supplement
5:10pm
clinical trial protocols and informed consent information for patients in clinical trials for the FDA.
Ischemic Injury
Injury caused by diminished … designed to reduce ischemic injury to organs and tissues in grafting and transplantation surgeries. These assets include DuraGraft, a first-in-class, De
8-K
EX-99.2
68pgq5u5marxqf qw19l
10 May 23
Marizyme Announces IP Developments for DuraGraft® and its Pipeline Products
8:30am